Myristic Acid

Myristic Acid

SCHEMBL3469991

CC(O)N(C(C)O)C(C)O.CCCCCCCCCCCCCC(=O)O

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.68
PPARG P37231 7/20 0.68
PPARD Q03181 7/20 0.68
PPARA Q07869 7/20 0.68
HDAC11 Q96DB2 5/20 0.68
TSHR P16473 4/20 0.68
PTPN1 P18031 3/20 0.68
FABP4 P15090 3/20 0.68
ALDH1A1 P00352 2/20 0.68
TLR2 O60603 2/20 0.68
TDP1 Q9NUW8 2/20 0.68
FFAR1 O14842 2/20 0.68
FFAR4 Q5NUL3 2/20 0.68
KMT2A Q03164 2/20 0.68
ALOX15 P16050 2/20 0.68
HSD17B10 Q99714 2/20 0.68
SLC22A6 Q4U2R8 1/20 0.68
SLC22A8 Q8TCC7 1/20 0.68
MEN1 O00255 1/20 0.68
ESR1 P03372 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Decanoic Acid SCHEMBL5874388 1.00 GPR84 (0.68) GPR84PPARGPPARDPPARAHDAC11
Dodecanoate SCHEMBL3470114 1.00 GPR84 (0.68) GPR84PPARGPPARDPPARAHDAC11
Octanoic Acid SCHEMBL5874222 1.00 GPR84 (0.68) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL919564 1.00 GPR84 (0.68) GPR84PPARGPPARDPPARAHDAC11
Nonanoate SCHEMBL5874623 1.00 GPR84 (0.68) GPR84PPARGPPARDPPARAHDAC11
Heptanoate SCHEMBL5874729 1.00 GPR84 (0.68) GPR84PPARGPPARDPPARAHDAC11
Behenic Acid SCHEMBL15973560 1.00 GPR84 (0.68) GPR84PPARGPPARDPPARAHDAC11
Palmitic Acid SCHEMBL5712837 1.00 GPR84 (0.68) GPR84PPARGPPARDPPARAHDAC11
Hexanoate SCHEMBL5874551 0.98 AKR1B1 (0.67) GPR84PPARGPPARDPPARAHDAC11
Valeric Acid SCHEMBL5874657 0.92 AKR1B1 (0.56) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8513174-B2 Cleanser SHISEIDO COMPANY LTD. (JP) 2013-08-20 US disclosed
EP-2251403-B1 CLEANSING COMPOSITION SHISEIDO CO LTD (JP) 2012-08-29 EP disclosed
US-20100317555-A1 Cleanser SHISEIDO COMPANY LTD. (JP) 2010-12-16 US disclosed
EP-2251403-A1 CLEANSING COMPOSITION Shiseido Company, Ltd. (JP) 2010-11-17 EP disclosed
EP-0442701-B1 Topical composition UNILEVER PLC (GB) 1996-04-24 EP disclosed
EP-0371801-A1 Topical composition UNILEVER PLC (GB) 1990-06-06 EP disclosed
EP-0371803-A1 Topical composition UNILEVER PLC (GB) 1990-06-06 EP disclosed
EP-0371802-A1 Topical composition UNILEVER PLC (GB) 1990-06-06 EP disclosed
EP-0371804-A1 Topical composition UNILEVER PLC (GB) 1990-06-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317555-A1 Cleanser STS, SGMS1, PTDSS1 GPR84 1327/4885PPARG 2025/4885PPARD 1841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.